Skip to main content
Log in

Recurrent Hepatitis C After Living Donor Liver Transplantation Detected by Tc-99m GSA Liver Scintigraphy

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Recurrence of hepatitis C virus (HCV) after living donor liver transplantation was investigated using technetium-99m- diethylenetriaminepentaacetic acid-galactosyl human serum albumin (Tc-99m-GSA) liver scintigraphy. Four patients with decompensated cirrhosis due to HCV infection were retrospectively reviewed in this study. Scintigraphy was performed to determine the hepatic uptake ratio of the tracer corrected for disappearance from the blood, as well as the maximal removal rate of the tracer by hepatocytes, as parameters of hepatic functional reserve. In all patients, serum HCV ribonucleic acid (RNA) was detected 3 months after transplantation. The corrected hepatic uptake ratio and removal rate showed little change after transplantation in two patients without the recurrence of HCV infection. In another two patients, these levels were decreased at 3 months after transplantation. In one patient, recurrent HCV infection was diagnosed by confirmatory histologic examination at 12 months after transplantation. In the other patient, both levels declined further at 8 months. Although treatment was initiated with a combination of interferon plus ribavirin, this patient died of progressive hepatic failure. In conclusion, a decrease in scintigraphic parameters at 3 months after transplantation suggests recurrent HCV infection affecting the graft. Tc-99m-GSA liver scintigraphy is a useful noninvasive method for evaluating graft functional reserve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Baltz AC, Trotter JF (2003) Living donor liver transplantation and hepatitis C. Clin Liver Dis 7:651–665

    Article  PubMed  Google Scholar 

  2. Gane EJ, Portmann BC, Naoumov NV, et al. (1996) Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 334:815–820

    Article  PubMed  CAS  Google Scholar 

  3. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR (2002) The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 122:889–896

    Article  PubMed  Google Scholar 

  4. Berenguer M, Ferrell L, Watson J, et al. (2000) HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 32:673–684

    Article  PubMed  CAS  Google Scholar 

  5. Samuel D, Bizollon T, Feray C, et al. (2003) Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 124:642–650

    Article  PubMed  CAS  Google Scholar 

  6. Burgess JB, Baenziger JU, Brown WR (1992) Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis. Hepatology 15:702–706

    PubMed  CAS  Google Scholar 

  7. Ha-Kawa SK, Tanaka Y, Hasebe S, et al. (1997) Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study. Eur J Nucl Med 24:130–137

    Article  PubMed  CAS  Google Scholar 

  8. Tomiguchi S, Kira T, Oyama Y, et al. (1995) Correlation of Tc-99m GSA hepatic studies with biopsies in patients with chronic active hepatitis. Clin Nucl Med 20:717–720

    Article  PubMed  CAS  Google Scholar 

  9. Kiuchi T, Uemoto S, Egawa H, et al. (2001) Living donor liver transplantation in Kyoto, 2001. Clin Transpl :195–201

  10. Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699

    Article  PubMed  CAS  Google Scholar 

  11. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293

    Article  PubMed  CAS  Google Scholar 

  12. Ha-Kawa SK, Suga Y, Ikeda K, Nagata K, Murata T, Tanaka Y (1993) Usefulness of blood disappearance corrected hepatic uptake ratio (LHL/HH) as a hepatic functional index using 99mTc-galactosyl serum albumin. Kakuigaku 30:1333–1339 (in Japanese with English abstract)

    CAS  Google Scholar 

  13. Ha-Kawa SK, Tanaka Y (1991) A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl Med 32:2233–2240

    PubMed  CAS  Google Scholar 

  14. Kira T, Tomiguchi S, Takahashi M, Yoshimatsu S, Sagara K, Kurano R (1999) Correlation of 99mTC-GSA hepatic scintigraphy with liver biopsies in patients with chronic active hepatitis type C. Radiat Med 17:125–130

    PubMed  CAS  Google Scholar 

  15. Troppmann C, Rossaro L, Perez RV, McVicar JP (2003) Early, rapidly progressive cholestatic hepatitis C reinfection and graft loss after adult living donor liver transplantation. Am J Transpl 3:239–240

    Article  Google Scholar 

  16. Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R (2004) Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States. Liver Transpl 10:340–346

    Article  PubMed  Google Scholar 

  17. Van Vierberghe H, Troisi R, Colle I, Ricciardi S, Praet M, de Hemptinne B (2004) Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults. Transplantation 77:210–214

    Article  Google Scholar 

  18. Mazzaferro V, Tagger A, Schiavo M, et al. (2001) Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment. Transplant Proc 33:1355–1357

    Article  PubMed  CAS  Google Scholar 

  19. Sugawara Y, Makuuchi M, Matsui Y, et al. (2004) Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation 78:1308–1311

    Article  PubMed  CAS  Google Scholar 

  20. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y (1997) Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 25:426–429

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaki Kaibori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaibori, M., Ha-Kawa, S.K., Uchida, Y. et al. Recurrent Hepatitis C After Living Donor Liver Transplantation Detected by Tc-99m GSA Liver Scintigraphy. Dig Dis Sci 51, 2013–2017 (2006). https://doi.org/10.1007/s10620-006-9534-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9534-1

Keywords

Navigation